Respiratory Medicine
Volume 101, Issue 10 , Pages 2139-2144 , October 2007

Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease

  • Ricard Pifarre

      Affiliations

    • Hospital Universitari Arnau de Vilanova, Service of Pneumology, Lleida, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34973248100; fax: +34973705273.
    • ,
  • Miquel Falguera

      Affiliations

    • Hospital Universitari Arnau de Vilanova, Service of Internal Medicine, Lleida, Spain
    • ,
  • Carmina Vicente-de-Vera

      Affiliations

    • Hospital Universitari Arnau de Vilanova, Service of Internal Medicine, Lleida, Spain
    • ,
  • Antonio Nogues

      Affiliations

    • Hospital Universitari Arnau de Vilanova, Service of Microbiology, Lleida, Spain

Received 18 September 2006 ,Accepted 16 May 2007.

References 

  1. Murray CJL, Lopez AD. Evidence-based health policy—lessons from the global burden of disease study. Science. 1996;274:740–743
  2. Falguera M, Martin M, Ruiz A, et al. Community acquired pneumonia as the initial manifestation of serious underlying disease. Am J Med. 2005;118:378–383
  3. Monso E, Ruiz J, Rosell A, et al. Infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med. 1995;152:1316–1320
  4. Carratala J, Ronson B, Fernadez Sevilla A. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotics therapy, and outcome. Arch Intern Med. 1998;158:868–872
  5. Janoff EN, O’Brien J, Thompson P, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis. 1993;167:49–56
  6. Falguera M, Pifarre R, Martin A, et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128:3233–3239
  7. Celli BR, MacNee W, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946
  8. Lorente ML, Falguera M, Nogués A, et al. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study. Thorax. 2000;55:133–137
  9. Falguera M, López A, Nogués A, et al. Evaluation of the PCR method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest. 2002;122:2212–2216
  10. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk-factors and prognosis. Arch Intern Med. 2002;162:1849–1858
  11. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999;160:397–405
  12. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of IBERPOC multicentre epidemiological study. Chest. 2000;118:981–989
  13. Ruiz de Ocaña JM, Gomez M, Celdran J, et al. Neumonía en el paciente con enfermedad pulmonar obstructiva crónica. Niveles de gravedad y clases de riesgo. Arch Bronconeumol. 2003;39:101–105
  14. Fernández-Sabe N, Carratalà J, Rosón B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore). 2003;82:159–169
  15. Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28:346–351
  16. Rello J, Rodríguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J. 2006;27:1210–1216
  17. Fine MJ, Auble TE, Xealdy DM, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250
  18. Sin DD, Man SFP, Thomas J, et al. Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia. Am J Med. 2005;118:145–150
  19. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–1754
  20. Normativas para el diagnostico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumologia y Cirugía Toracica (SEPAR). Arch Bronconeumol. 2005;41:272–289
  21. Torres A, Serra–Batlles A, Ferrer A, et al. Severe community-acquired pneumonia. Am Rev Respir Dis. 1991;144:312–318
  22. Lieberman D, Lieberman D, Gelfer Y. Pneumonic versus nonpneumonic acute exacerbations of COPD. Chest. 2002;122:1264–1270

PII: S0954-6111(07)00215-6

doi: 10.1016/j.rmed.2007.05.011

Respiratory Medicine
Volume 101, Issue 10 , Pages 2139-2144 , October 2007

Article Tools